首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Evaluation of the acute and chronic toxicity of the jiangu capsules
【2h】

Evaluation of the acute and chronic toxicity of the jiangu capsules

机译:健骨胶囊的急慢性毒性评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Saussureae involucratae Flos is the primary component of the jiangu capsule, which also consists of 12 types of natural medicine. It is a traditional Chinese medicine used to treat a number of conditions including arthralgia, cold and sore muscles, stiff limbs, inconvenient flexion and activity limitation caused by different types of osteoarthritis. The present study was performed to assess the safety of the jiangu capsule following acute and chronic administration in mice and rats. In the acute study, mice were treated with the jiangu capsule orally at 16 g/kg/day, the highest dose, for 14 days. In the chronic oral toxicity study, rats were treated with 2, 4 and 8 g/kg/day of the jiangu capsule for 6 months. The general condition, body weight changes, food and water consumption, hematological and biochemical parameters, urinalysis, systematic anatomy and organ weights of the rats were monitored and histopathological examination was performed at the end of 3 and 6 months' daily administration, and following 14 days of withdrawal. There were no signs of toxicity in the general condition and body weight of the mice was not significantly affected by the treatment. Furthermore, necropsy findings for the animals in the acute and chronic toxicity studies demonstrated that no mortalities had occurred. The results of the current study indicate that treatment with the jiangu capsule did not induce mortality or any detectable abnormalities in mice and rats.
机译:雪莲果是剑菇胶囊的主要成分,它还包含12种天然药物。这是一种传统中药,可用于治疗多种病症,包括关节痛,肌肉酸痛和疼痛,四肢僵硬,屈曲不便以及各种类型的骨关节炎引起的活动受限。进行本研究以评估在小鼠和大鼠中急性和慢性给药后剑骨胶囊的安全性。在急性研究中,以最高剂量16 g / kg / day口服jianu胶囊治疗小鼠14天。在慢性口服毒性研究中,大鼠每天以2、4和8 g / kg / kg的剑骨胶囊治疗6个月。监测大鼠的一般情况,体重变化,食物和水消耗,血液学和生化参数,尿液分析,系统解剖学和器官重量,并在每天给药3个月和6个月结束时进行组织病理学检查,然后进行14次提款天数。在一般情况下没有毒性的迹象,并且小鼠的体重没有受到治疗的显着影响。此外,在急性和慢性毒性研究中对动物的尸检结果表明没有死亡。当前研究的结果表明,用健骨胶囊治疗不会在小鼠和大鼠中诱发死亡率或任何可检测到的异常。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号